Registry for CADASIL

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT05567744
Status
Recruiting

Conditions

  • Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • Registry — OTHER
    Registry

Study Details

This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.

Key Dates

Start date
Jun 3, 2022
Status verified
Oct 2025
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
2,500 participants (estimated)

Arms

  • Arm: CADASIL Registry Participants
    Have a loved one or family member with CADASIL, or anyone with or at risk for CADASIL

Primary Outcome Measure

A Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Registry [ Time Frame: Up to 20 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of WisconsinMadisonWisconsin53705
CADASIL Consortium
833-795-3016
Jane Paulsen, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Madison, WI